Regeneron Pharmaceuticals (REGN) expands its focus on eye care with the acquisition of Oxular, a U.K.-based biotech ...

Regeneron has bought Oxular, a UK-based specialist in retinal diseases, in a move that bolsters its already strong position ...

Regeneron has scooped up Oxular, a retinal-disease-focused company based in the U.K., closing the deal at the very end of ...

Eye diseases are conditions that affect the eyes, leading to vision impairment or loss. Common types include cataracts, glaucoma, macular degeneration, diabetic retinopathy, and retinal diseases.

Since July 2024, faricimab has also been approved in Europe for the treatment of visual impairment due to macular oedema ...

These are the best vitamins and supplements for eye health, which are great for supporting your vision and helping you take ...

A two-ingredient drink that combines carrot with a spice can boost your energy levels, prevent inflammation in the body and ...

Combining these commonly found ingredients into a drink could protect against arthritis and strengthen the immune system ...

INV-102 is under clinical development by Invirsa and currently in Phase II for Diabetic Macular Edema. According to GlobalData, Phase II drugs for Diabetic Macular Edema have a 47% phase transition ...

Danicopan is under clinical development by Alexion Pharmaceuticals and currently in Phase II for Coronavirus Disease 2019 (COVID-19).

INR:2655. new rummy app 100 500 bonus download Gene therapy for macular degeneration enters clinical trials with £50.4 million Series B fina ...